Public Policy Resources

Share

ACS CAN & Federal Tobacco Litigation - An Overview

October 25, 2024

The tobacco industry has a history of using litigation to avoid and delay laws and regulations enacted to safeguard the public. The American Cancer Society Cancer Action Network (ACS CAN), with our tobacco control partners, has also relied on the courts to hold Big Tobacco accountable and to ensure the federal government is effectively implementing the Tobacco Control Act. Through ACS CAN’s Judicial Advocacy Initiative, we have worked to ensure public health interests are effectively represented by filing our own cases against the Food and Drug Administration (FDA), weighing into other important court disputes by filing   amicus curiae or “friend of the court” briefs, and intervening in a major lawsuit. This fact sheet briefly summarizes major active tobacco control cases at the federal level.   

PDF icon ACS CAN & Federal Tobacco Litigation - An Overview Fact Sheet Final 10.25.24

Related Resources

History of the Racketeering Lawsuit Against the Tobacco Industry: Guilty of Deceiving the American Public

November 8, 2024

In 1999, the U.S. Department of Justice (DOJ) filed a lawsuit against major tobacco manufacturers Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria to hold the industry accountable for more than 50 years of conspiring to defraud the public in violation of the Racketeer Influenced and Corrupt Organizations (RICO) Act. Big Tobacco, an industry which has for decades knowingly addicted and endangered the lives of millions of Americans for their own profit, must now post the truth about their deadly products, including at the point-of-sale (POS) for approximately 220,000 tobacco retailers.

Read more

Delayed Implementation of Graphic Warning Labels on Cigarettes Harms Public Health

October 25, 2024

Implementation of graphic warnings in the U.S. has been thwarted by tobacco industry legal challenges. The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN), along with our partners, have fought back in the judicial system, using litigation to both compel the U.S. Food and Drug Administration (FDA) to issue graphic warning regulations and help the U.S. Department of Justice (DOJ) defend the regulations finalized by FDA.

Read more